Does BREXUCABTAGENE AUTOLEUCEL Cause Dysgraphia? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Dysgraphia have been filed in association with BREXUCABTAGENE AUTOLEUCEL (TECARTUS). This represents 0.6% of all adverse event reports for BREXUCABTAGENE AUTOLEUCEL.
11
Reports of Dysgraphia with BREXUCABTAGENE AUTOLEUCEL
0.6%
of all BREXUCABTAGENE AUTOLEUCEL reports
1
Deaths
6
Hospitalizations
How Dangerous Is Dysgraphia From BREXUCABTAGENE AUTOLEUCEL?
Of the 11 reports, 1 (9.1%) resulted in death, 6 (54.5%) required hospitalization.
Is Dysgraphia Listed in the Official Label?
Yes, Dysgraphia is listed as a known adverse reaction in the official FDA drug label for BREXUCABTAGENE AUTOLEUCEL.
What Other Side Effects Does BREXUCABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (827)
Immune effector cell-associated neurotoxicity syndrome (529)
Neurotoxicity (192)
Death (153)
Pyrexia (119)
Hypotension (109)
Disease progression (93)
Fatigue (86)
Febrile neutropenia (69)
Confusional state (63)
What Other Drugs Cause Dysgraphia?
DIMETHYL (238)
PREGABALIN (233)
DALFAMPRIDINE (226)
FINGOLIMOD (222)
VALPROATE (199)
INTERFERON BETA-1A (191)
TOFACITINIB (185)
NATALIZUMAB (171)
PIMAVANSERIN (161)
TERIFLUNOMIDE (141)
Which BREXUCABTAGENE AUTOLEUCEL Alternatives Have Lower Dysgraphia Risk?
BREXUCABTAGENE AUTOLEUCEL vs BRIGATINIB
BREXUCABTAGENE AUTOLEUCEL vs BRILINTA
BREXUCABTAGENE AUTOLEUCEL vs BRILIQUE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE
BREXUCABTAGENE AUTOLEUCEL vs BRIMONIDINE\BRINZOLAMIDE